FAIRplus: D5.03 FAIRplus Handbook and project monitoring

This report provides an overview of the development of the FAIRplus Project Handbook and the project monitoring activities implemented and carried out during the first 12 months of the IMI2 JU FAIRplus project, including: Key Performance Indicators (KPIs), risk management, financial monitoring, project sustainability, and lessons learned.

The FAIRplus project is developing tools and guidelines for making life science data Findable, Accessible, Interoperable, Reusable (FAIR). The goal of FAIRplus is to deliver guidelines and tools to facilitate the application of ‘FAIR’ principles to data from Innovative Medicines Initiative projects and datasets from pharmaceutical companies, which will result in increased discoverability, accessibility and reusability of the data. The increased FAIRness of data will in turn lead to a wider sharing of knowledge, greater opportunities for innovation, and more insights that benefit society.

The project has 22 partners from academia and industry, and runs from January 2019 to June 2022. More information: https://fairplus-project.eu/

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 802750. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation and EFPIA companies.